More Articles

Biosimilars of etanercept Biosimilars/General | Posted 20/06/2014

Last update: 5 August 2016Etanercept is a biological drug that treats autoimmune diseases by inhibiting tumour necrosis factor (TNF); a soluble inflammatory cytokine. Etanercept is indicated f...

Factors influencing use of generic asthma drugs in Morocco Generics/Research | Posted 20/06/2014

Despite the introduction of methods to promote the use of generics, use of generic anti-asthmatic drugs remains limited in Morocco. The Moroccan market therefore remains largely dominated by patent...

Actavis settles Nuvigil patent litigation, challenges Onglyza patent Generics/News | Posted 20/06/2014

US generics major Actavis has settled patent litigation related to Actavis’ generic version of Nuvigil (armodafinil) and confirmed its generic Onglyza (saxagliptin) patent challenge.

WHO calls for better science-based regulations for biosimilars Policies & Legislation | Posted 13/06/2014

The sixty-seventh World Health Assembly (WHA) of the World Health Organization (WHO) closed on 24 May 2014, after adopting more than 20 resolutions on public health issues of global importance, one...

Biosimilars of epoetin alfa Biosimilars/General | Posted 13/06/2014

Last update: 4 November 2016Epoetin alfa is a human erythropoietin produced in cell culture using recombinant DNA technology. It stimulates erythropoiesis (increases red blood cell levels) and...

Promoting generics prescribing in the UK Generics/Research | Posted 13/06/2014

Possible ways to encourage more prescribing of generics in the UK include financial incentives with educational intervention and audit/feedback, according to a review of data on prescribing behavio...

Draft guide on monitoring medical literature released for public consultation Guidelines | Posted 13/06/2014

On 5 June 2014, the European Medicines Agency (EMA) released a draft guide on the monitoring of medical literature and the entry of relevant information into the EudraVigilance database. The draft...

The global biologicals market Reports | Posted 13/06/2014

Global spending on medicines is expected to reach the US$1 trillion threshold in 2014 and rise to US$1.2 trillion by 2017.